Acadia Healthcare Company, Inc. — Form 8-K
Filed September 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Acadia Healthcare settled three consolidated shareholder derivative actions (federal and Delaware state courts) alleging fiduciary breaches, insider trading, and misleading disclosures regarding compliance, quality of care, staffing, and UK operations. Settlement: $12M cash payment from D&O insurers to company + 4-year corporate governance reforms (disclosure committee, insider trading policy, clawback policy enhancements, whistleblower protections, Chief Quality Officer oversight, Technology Committee, compensation committee reforms). Plaintiffs' counsel receive $4.75M in fees/expenses (subject to court approval); each of three plaintiffs may receive $5K service awards. All derivative claims dismissed with prejudice upon court approval and settlement effectiveness.
Why this rating
Material but routine: ~$12M settlement (~0.57% of $2.1B market cap) is modest. Governance reforms are substantive but standard post-litigation practice. No admission of wrongdoing; cost spread across insurers. Typical derivative settlement outcome.
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.